参考文献
［1］NAGINO M，EBATA T，YOKOYAMA Y，et al.Evolution of surgical treatment for perihilar cholangiocarcinoma：a single-center 34-year review of 574 consecutive resections［J］.Ann Surg，2013，258（1）：129-140.
［2］KAWASHIMA H，ITOH A，OHNO E，et al.Preoperative endoscopic nasobiliary drainage in 164 consecutive patients with suspected perihilar cholangiocarcinoma：a retrospective study of efficacy and risk factors related to complications［J］.Ann Surg，2013，257（1）：121-127.
［3］TSUCHIKAWA T，HIRANO S，OKAMURA K，et al.Advances in the surgical treatment of hilar cholangiocarcinoma［J］.Expert Rev Gastroenterol Hepatol，2015，9（3）：369-374.
［4］RASSAM F，ROOS E，VAN LIENDEN K P，et al.Modern work-up and extended resection in perihilar cholangiocarcinoma：the AMC experience［J］.Langenbecks Arch Surg，2018，403（3）：289-307.
［5］TAMADA K，USHIO J，SUGANO K.Endoscopic diagnosis of extrahepatic bile duct carcinoma：Advances and current limitations［J］.World J Clin Oncol，2011，2（5）：203-216.
［6］KAWAKAMI H，KUWATANI M，ONODERA M，et al.Endoscopic nasobiliary drainage is the most suitable preoperative biliary drainage method in the management of patients with hilar cholangiocarcinoma［J］.J Gastroenterol，2011，46（2）：242-248.
［7］KANAZAWA H，NAGINO M，KAMIYA S，et al.Synbiotics reduce postoperative infectious complications：a randomized controlled trial in biliary cancer patients undergoing hepatectomy［J］.Langenbecks Arch Surg，2005，390（2）：104-113.
［8］RATTI F，CIPRIANI F.Hilar cholangiocarcinoma：preoperative liver optimization with multidisciplinary approach.Toward a better outcome［J］.World J Surg，2013，37（6）：1388-1396.
［9］NIMURA Y，HAYAKAWA N，KAMIYA J，et al.Hepatopancreatoduodenectomy for advanced carcinoma of the biliary tract［J］.Hepatogastroenterology，1991，38（2）：170-175.
［10］AOKI T，SAKAMOTO Y，KOHNO Y，et al.Hepatopancreaticoduodenectomy for biliary cancer：strategies for near-zero operative mortality and acceptable long-term outcome［J］.Ann Surg，2016，267（2）：332-337.
［11］SAKAMOTO Y，NARA S，KISHI Y，et al.Is extended hemihepatectomy plus pancreaticoduodenectomy justified for advanced bile duct cancer and gallbladder cancer？［J］.Surgery，2013，153（6）：794-800.
［12］OETTLE H，POST S，NEUHAUS P，et al.Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer：a randomized controlled trial［J］.JAMA，2007，297（3）：267-277.
［13］WEIGT J，MALFERTHEINER P.Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer［J］.Expert Rev Gastroenterol Hepatol，2010，4（4）：395-397.
［14］VALLE J，WASAN H，PALMER D H，et al.Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer［J］.N Engl J Med，2010，362（14）：1273-1281.
［15］MCMASTERS K M，TUTTLE T M，LEACH S D，et al.Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma［J］.Am J Surg，1997，174（6）：605-608.
［16］GERHARDS M F，VAN GULIK T M，GONZÁLEZ GONZÁLEZ D，et al.Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma［J］.World J Surg，2003，27（2）：173-179.
［17］ISAYAMA H，TSUJINO T，NAKAI Y，et al.Clinical benefit of radiation therapy and metallic stenting for unresectable hilar cholangiocarcinoma［J］.World J Gastroenterol，2012，18（19）：2364-2370.
［18］KONGKAM P，TASNEEM A A，RERKNIMITR R.Combination of endoscopic retrograde cholangiopancreatography and endoscopic ultrasonography-guided biliary drainage in malignant hilar biliary obstruction［J］.Dig Endosc，2019，31（Suppl 1）：50-54.
［19］ORTNER M E，CACA K，BERR F，et al.Successful photodynamic therapy for nonresectable cholangiocarcinoma：a randomized prospective study［J］.Gastroenterology，2003，125（5）：1355-1363.
［20］KRIEGSMANN M，ROESSLER S，KRIEGSMANN K，et al.Programmed cell death ligand 1（PD-L1，CD274）in cholangiocarcinoma-correlation with clinicopathological data and comparison of antibodies［J］.BMC Cancer，2019，19（1）：72.
［21］MOU H，YU L，LIAO Q，et al.Successful response to the combination of immunotherapy and chemotherapy in cholangiocarcinoma with high tumour mutational burden and PD-L1 expression：a case report［J］.BMC Cancer，2018，18（1）：1105.
［22］FISHER S B，PATEL S H，KOOBY D A，et al.Lymphovascular and perineural invasion as selection criteria for adjuvant therapy in intrahepatic cholangiocarcinoma：a multi-institution analysis［J］.HPB（Oxford），2012，14（8）：514-522.
［23］BLAIR A B，MURPHY A.Immunotherapy as a treatment for biliary tract cancers：A review of approaches with an eye to the future［J］.Curr Probl Cancer，2018，42（1）：49-58.